In a filing, Spero Therapeutics Inc revealed its CEO and President Shukla Sath unloaded Company’s shares for reported $65385.0 on Feb 05 ’24. In the deal valued at $1.45 per share,45,093 shares were sold. As a result of this transaction, Shukla Sath now holds 1,176,007 shares worth roughly $1.78 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Mahadevia Ankit sold 63,795 shares, generating $87,399 in total proceeds. Upon selling the shares at $1.37, the Director now owns 744,997 shares.
Before that, JOSEPH TAMARA L sold 30,906 shares. Spero Therapeutics Inc shares valued at $42,341 were divested by the Chief Legal Officer at a price of $1.37 per share. As a result of the transaction, JOSEPH TAMARA L now holds 531,615 shares, worth roughly $0.8 million.
Evercore ISI upgraded its Spero Therapeutics Inc [SPRO] rating to an Outperform from a an In-line in a research note published on September 23, 2022; the price target was increased to $8 from $2. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who decreased its forecast for the stock in early October from “an Outperform” to “a Perform”. H.C. Wainwright also remained covering SPRO and reiterated its “Buy” recommendation on January 22, 2021. Berenberg started covering the stock on December 16, 2020. It rated SPRO as “a Buy”.
Price Performance Review of SPRO
On Tuesday, Spero Therapeutics Inc [NASDAQ:SPRO] saw its stock fall -3.21% to $1.51. Over the last five days, the stock has lost -5.63%. Spero Therapeutics Inc shares have risen nearly 2.72% since the year began. Nevertheless, the stocks have fallen -18.38% over the past one year. While a 52-week high of $1.94 was reached on 03/14/24, a 52-week low of $0.99 was recorded on 02/08/24. SMA at 50 days reached $1.6243, while 200 days put it at $1.4055. A total of 0.21 million shares were traded, compared to the trading of 0.23 million shares in the previous session.
Levels Of Support And Resistance For SPRO Stock
The 24-hour chart illustrates a support level at 1.4867, which if violated will result in even more drops to 1.4633. On the upside, there is a resistance level at 1.5467. A further resistance level may holdings at 1.5833. The Relative Strength Index (RSI) on the 14-day chart is 41.58, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0652, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 95.45%. Stochastics %K at 35.35% indicates the stock is a holding.
The most recent change occurred on September 29, 2020 when Evercore ISI began covering the stock and recommended ‘”an Outperform”‘ rating.
